Summary: The big pharmaceutical companies have always had a choice: whether to place their focus on the patient or on profits. Every pharmaceutical company (Eli Lilly has determined that they are a “medicine company’) will attempt to present as being there for the people, and they will have a business plan that is about profits and the “health” of the company. But Big Pharma is not in the clothing or automobile business…they are in the “health of the people” business. So why develop a drug that – due to its price – may be out of reach for the average patient in need? Profits for the drug company are expected, but to what extent, and at what cost?
Topics:
· Name it to Hate it 01:30
· Public Distrust in Big Pharma 03:00
($$$, Concealing Facts about Safety, Patents)
· Research & Development/Rx Sales 04:15
· Humira – a monoclonal antibody 06:40
· New Drug Application & Patent 07:00
· More Patents and More Money 08:20
· Biosimilar Options Prevented 09:00
· Enbrel 09:45
· Meds for the People 10:30
· Bernie Sanders – HELP Committee 11:15
· Drug Advertising 12:15
· Vioxx 13:55
· Purdue Pharma – Oxycontin 14:40
· Free Lunches 16:50
· Big Pharma Lobbyists 18:00
· 1800 Lobbyists for 535 Members of Congress 20:00
· Be a Lobbyist for You! 20:30
· In the Meantime – Pharmacoeconomics 21:20
· Monitor – Journal – Communicate 22:45
· Know what we Don’t Know 22:20
· Greed is Real 26:40
· Participate 27:40
Questions and comments to druggistforthepeople@gmail.com
